Vertex Pharmaceuticals Incorporated (VRTX): calculated intrinsic value vs market price

Calculated intrinsic value vs market price

Vertex Pharmaceuticals Incorporated (VRTX) current market price $547.65; calculated gap vs modeled fair value is 8.23%. The dollar intrinsic value estimate is available with Tickerplace Pro.

  • Fair value gap (live) 8.23% (from live valuation API)
  • Confidence (live) 4/10 (Small gap)

Confidence score is based on the magnitude of the gap vs the modeled estimate.

Fair value estimate

Unlock fair value

Current price

$547.65

Explore Our Valuation Calculators

How to read the price vs calculated fair value gap for Vertex Pharmaceuticals Incorporated

Intrinsic value for Vertex Pharmaceuticals Incorporated (VRTX) is estimated from cash flows, growth, reinvestment, and a risk-adjusted discount rate, then compared with the current market price.

A second lens is historical valuation: today’s multiple versus the company’s own five-year average. That comparison describes where the multiple sits relative to past ranges — it is not a buy or sell conclusion.

Market price also embeds assumptions about revenue, margins, and capital returns. Use the ratios and financials linked on this page to see the inputs behind the calculated gap.

Key metrics

P/E ratio
47.4x
Revenue growth (TTM y/y)
20%
Profit margin
40.7%
Fair value (model)
Unlock

Frequently asked questions — VRTX

What is VRTX’s calculated intrinsic value vs its market price?

Vertex Pharmaceuticals Incorporated (VRTX) current market price is $547.65, a calculated difference of 8.2% versus modeled fair value. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.

What is Vertex Pharmaceuticals Incorporated's intrinsic value?

Intrinsic value is an estimate of what VRTX shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Vertex Pharmaceuticals Incorporated's intrinsic value calculated?

Tickerplace calculates VRTX's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.

How should I read VRTX’s fair value gap?

VRTX’s calculated gap versus modeled fair value is 8.2% at a market price of $547.65. A gap is a calculated difference between price and the model estimate, not a buy or sell conclusion. Confirm with ratios and financials on the company profile.